Close Menu

NEW YORK (GenomeWeb) – Abbott announced today that the US Food and Drug Administration has expanded the Emergency Use Authorization for the company's RealTime Zika assay to now include use on whole blood samples.

The agency originally granted the assay EUA in November for use on human serum, EDTA plasma, and urine samples. Now, Abbott will also be able to use the test for detection of the Zika virus in whole blood, when collected alongside patient-matched serum or plasma samples.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test. 

Apr
16
Sponsored by
Thermo Fisher Scientific

With COVID-19 vaccines rolling out, clinical labs and test developers are preparing for changes in both demand for testing and types of testing for SARS-CoV-2.